Search
for
Sort by
Research 361–390 of 1000+
- Acute Selenium Toxicity Associated With a Dietary Supplement
- Finasteride
- A review of diagnosis and treatment of acne in adult female patients
- CHRONIC TREATMENT WITH FINASTERIDE DAILY DOES NOT AFFECT SPERMATOGENESIS OR SEMEN PRODUCTION IN YOUNG MEN
- Association of Suicidality and Depression With 5α-Reductase Inhibitors
- Acute Hepatitis Due to Shen-Min
- Treatment of an alopecia areata patient with tofacitinib results in regrowth of hair and changes in serum and skin biomarkers
- Case Report: Potential Arsenic Toxicosis Secondary to Herbal Kelp Supplement
- Assessment of the obese patient
- Hair Loss in Psychopharmacology
- Effects of the 5α-Reductase Inhibitor Finasteride on Serum Levels of Gonadal, Adrenal, and Hypophyseal Hormones and its Clinical Significance: A Prospective Clinical Study
- Cutaneous effects of the most commonly used antidepressant medication, the selective serotonin reuptake inhibitors
- Anti‐androgens may protect against severe COVID‐19 outcomes: results from a prospective cohort study of 77 hospitalized men
- Chemotherapy‐induced alopecia management: Clinical experience and practical advice
- Dietary supplement increases anagen hair rate in women with telogen effluvium: results of a double-blind, placebo-controlled trial
- Hirsutism: Diagnosis and management
- Five-alpha-reductase Inhibitors for prostate cancer prevention.
- 5‐alpha‐reductase inhibitors are associated with reduced frequency of COVID‐19 symptoms in males with androgenetic alopecia
- A Review of the FAERS Data on 5-Alpha Reductase Inhibitors: Implications for Postfinasteride Syndrome
- One of These Things Is Not Like the Others: The Idea of Precedence in Health Technology Assessment and Coverage Decisions
- Leydig Cell Hyperplasia and Adenomas in Mice Treated with Finasteride, a 5α-Reductase Inhibitor: A Possible Mechanism
- Sex differences in the effect of finasteride on acute ethanol withdrawal severity in C57BL/6J and DBA/2J mice
- The measurement of a new antimicrobial quinolone in hair as an index of drug exposure.
- Progesterone, neurosteroids, and the hormonal basis of catamenial epilepsy
- Review of Cardiovascular Findings in Humans Treated with Minoxidil
- The Neurosteroidogenic Enzyme 5α-Reductase Mediates Psychotic-Like Complications of Sleep Deprivation
- How to Diagnose Hair Loss
- Gonadal Suppressive and Cross‐Sex Hormone Therapy for Gender Dysphoria in Adolescents and Adults
- Characteristics of robotically harvested hair follicles in Koreans
- Safety of 5α-reductase inhibitors and spironolactone in breast cancer patients receiving endocrine therapies